The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

It has only been recent that birth defects and injuries caused by mothers taking Depakote during their pregnancy have been discussed publicly. Depakote was first approved by the Food and Drug Administration (FDA) in 1978 for treatment of epilepsy. However, more cases of birth defects associated with Depakote are coming to light.

According to the labeling information for Depakote, the drug has been linked to deformed bones, Spina Bifida, heart defects, and even fetal death. The FDA has insisted on having a black box warning placed on Depakote’s prescribing label informing women who are pregnant or considering having children to find an alternative medication to Depakote for the treatment of epilepsy.

If your child was born with birth defects as a result of your use of Depakote, please contact Sheller, P.C.

Comments are closed.

Of Interest